Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
Journal: The New England journal of medicine
Published: August 28, 2026
Plasma Metabolite Associations with Incident Heart Failure with Reduced and Preserved Ejection Fraction.
Journal: medRxiv : the preprint server for health sciences
Published: August 01, 2026
Efficacy of Aficamten vs Metoprolol According to Pretrial Beta-Blocker Treatment in Obstructive Hypertrophic Cardiomyopathy: Insights From MAPLE-HCM.
Journal: JACC. Heart failure
Published: June 08, 2026
Novel Use of Mavacamten in RAF1-Associated Noonan Syndrome With Hypertrophic Cardiomyopathy.
Journal: JACC. Case reports
Published: April 28, 2026
Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract Gradients.
Journal: The American journal of cardiology
Published: February 26, 2026
Effect of Aficamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy in SEQUOIA-HCM.
Journal: Circulation. Heart failure
Published: November 08, 2025
Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial.
Journal: Journal of the American College of Cardiology
Published: October 11, 2025
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy.
Journal: The New England journal of medicine
Published: September 01, 2025
Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM.
Journal: Journal of the American College of Cardiology
Published: July 24, 2025
Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM.
Journal: Journal of cardiac failure
Published: July 23, 2025
Last Updated: 09/26/2026